Smartway Pharmaceuticals

Smartway Pharmaceuticals Designs, Implements, and Manages Global Early/Expanded Access Programs to Enhance Drug Availability Worldwide and Help Transform Lives. We collaborate with pharmaceutical and biotechnology companies who trust Smartway’s leadership in delivering expanded access, early access, compassionate use, and named patient programs across 98 countries. Over the past 20 years, we have accumulated the expertise needed to provide strategic advice, design, launch, and manage global or regional projects for biotechnology and pharmaceutical industries. As part of its specialized services, Smartway offers end-to-end solutions to manage complex EAPs, regardless of their scope and scale, with a commitment to ensuring patients gain access to the right treatment.